Glenmark, Canada's SaNOtize to commercialise nasal spray for Covid-19 treatment

Aug 02, 2021

Mumbai (Maharashtra) [India], August 2 : Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research and Development Corp on Monday announced an exclusive long term...

First nasal spray for treating adult COVID-19 patients launched in India

Feb 09, 2022

New Delhi [India], February 9 : Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership...

Glenmark launches Nitric Oxide Nasal Spray (FabiSpray®) in India for the Treatment of Adult Patients with COVID-19 in partnership with SaNOtize

Feb 09, 2022

Mumbai (Maharashtra) [India], February 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) - a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development...

Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trials on NONS Spray for COVID-19 in Lancet Journal

Jul 13, 2022

Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today...